The increased incidence of PML in the anti-adhesion therapy treated patients has been postulated to be likely due to increased escape of progenitor and immature cells from their bone marrow niche (where they are held via α4β1:VCAM-1 interaction) into circulation, carrying JC virus with them. The gene discussed is VCAM1; the disease is progressive multifocal leukoencephalopathy.